Celebrating Australian women in nuclear
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.
Showing 101 - 120 of 244 results
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.
Nine PhD students are taking part in a rare opportunity to deliver an innovative solution to a real-world challenge for an industry partner in ANSTO’s National Graduate Innovation Forum in association with the Australian Council of Deans of Science and the Australian Institute of Nuclear Science and Engineering.
Accurate ‘fingerprinting’ tool to verify source of origin is in development with collaborators from academia and industry.
See details of previously published customer updates from our Health products team.
The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.
Improving aquaculture for food production in Papua New Guinea
Darren Mason is a senior business leader with over 30 years of experience in the nuclear, radiation, petrochemical, freight and energy sectors. He joined ANSTO in 2023 in a key role managing consultancy for calibration, training, nuclear waste and radi
A lesson in Science and Sustainability.
The Graduate Institute is part of ANSTO’s Innovation Precinct and links all graduates together to create a network of Australia’s brightest young minds focused on the future.
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Using geoarchaeology to reconstruct the history of an ancient Khmer city.
The Government is safeguarding Australia’s sovereign capability to produce vital nuclear medicines by launching a $30 million project to design a new world-leading manufacturing facility to be built at Lucas Heights in Sydney.